Biosafety assessment of Bifidobacterium animalis subsp. lactis AD011 used for human consumption as a probiotic microorganism
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
In this work, the previously identified Bifidobacterium strain, Bifidobacterium animalis subsp. lactis AD011 (obtained from an infant fecal sample), intended as a potential probiotic microorganism, is assessed for its safety using multiple in vitro virulence assays (ammonia and biogenic amine synthesis, hemolytic and mucin degradation activities, antimicrobial susceptibility and conjugal transferability of antibiotic resistance genes to other microorganisms) and comparative genomic analysis. The genome data of B. lactis AD011 was compared with genome sequences of two commercially available probiotic microorganisms (Bifidobacterium lactis BB-12 and Bifidobacterium lactis Bl-04) which are designated as generally recognized as safe by the U.S. Food and Drug Administration. The results of these experiments showed no significant potential vulnerabilities and no side effects. B. lactis AD011 showed higher resistance to tetracycline than the European Food Safety Authority cut-off. However, the measured susceptibility is similar to or lower than that of other previously certified GRAS Bifidobacterium strains. Tetracycline resistance of B. lactis AD011 was not conveyed via conjugation with L. fermentum AGBG1, which is susceptible to tetracycline. Complete DNA sequencing of B. lactis AD011 showed the absence of transferable drug resistance plasmids. The three B. lactis strains (AD011, BB12 and Bl-14) compared in this study were found to share very close genomic sequence homology (>99.8 %). Therefore, based on this study, B. lactis AD011 appears to be a safe, bioactive, bifidobacterial food ingredient, starter culture, and/or probiotic microorganism for human health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(BIOHAZ), E. P. O. B. H. (2011) · EFSA Journal · doi:10.2903/j.efsa.2011.2393 · Cited by 995
Next-generation probiotics: the spectrum from probiotics to live biotherapeutics
O’Toole, P. W., Marchesi, J. R., & Hill, C. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.57 · Cited by 971
(FEEDAP), E. P. O. A. A. P. O. S. U. I. A. F. (2012) · EFSA Journal · doi:10.2903/j.efsa.2012.2740 · Cited by 904
Benefaction of probiotics for human health: A review
George Kerry, R., Patra, J. K., Gouda, S., Park, Y., Shin, H.-S., & Das, G. (2018) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.01.002 · Cited by 898
Safety assessment of probiotics for human use
Sanders, M. E., Akkermans, L. M. A., Haller, D., Hammerman, C., Heimbach, J. T., Hörmannsperger, G., & Huys, G. (2010) · Gut Microbes · doi:10.4161/gmic.1.3.12127 · Cited by 816
Akkermansia muciniphila is a promising probiotic
Zhang, T., Li, Q., Cheng, L., Buch, H., & Zhang, F. (2019) · Microbial Biotechnology · doi:10.1111/1751-7915.13410 · Cited by 708
The Genus Enterococcus: Between Probiotic Potential and Safety Concerns—An Update
Hanchi, H., Mottawea, W., Sebei, K., & Hammami, R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01791 · Cited by 569
Biogenic Amine Production by Lactic Acid Bacteria: A Review
Barbieri, F., Montanari, C., Gardini, F., & Tabanelli, G. (2019) · Foods · doi:10.3390/foods8010017 · Cited by 528
Lactobacillus species: Taxonomic complexity and controversial susceptibilities
Goldstein, E. J. C., Tyrrell, K. L., & Citron, D. M. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ072 · Cited by 392
Kelesidis, T., & Pothoulakis, C. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x11428502 · Cited by 377
Prevalence of antibiotic resistance genes among human gut-derived bifidobacteria
Duranti, S., Lugli, G. A., Mancabelli, L., Turroni, F., Milani, C., Mangifesta, M., Ferrario, C., Anzalone, R., Viappiani, A., van Sinderen, D., et al. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.02894-16 · Cited by 103
Cited by
da Silva, T. F., Glória, R. D. A., Americo, M. F., Freitas, A. D. S., de Jesus, L. C. L., Barroso, F. A. L., Laguna, J. G., Coelho-Rocha, N. D., Tavares, L. M., le Loir, Y., et al. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10247-x · Cited by 117
“The potential production of BAs by Bifidobacterium animalis subsp. lactis AD011, isolated from an infant fecal sample, was recently investigated using a metabolomics approach through LC/MS–MS analysis [104, 105].”
Castro-López, C., García, H. S., Guadalupe Martínez-Ávila, G. C., González-Córdova, A. F., Vallejo-Cordoba, B., & Hernández-Mendoza, A. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.12.017 · Cited by 72
Next-generation probiotics: Innovations in safety assessments
Hua, Z., Liu, S., Yang, G., Hou, X., & Fang, Y. (2025) · Current Opinion in Food Science · doi:10.1016/j.cofs.2024.101238 · Cited by 29
Metadata
- Authors
- Ku, S., Yang, S., Lee, H. H., Choe, D., Johnston, T. V., Ji, G. E., & Park, M. S.
- Venue
- Food Control
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 117
- Pages
- 106985
- ISSN
- 0956-7135 (ISSN-L)
- OpenAlex
- W2987589871
- Cited by
- 43
- References
- 11
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.